Encouraging New Research About Virotherapy for Myeloma

The IMF is very pleased to see research from Dr. Stephen Russell at the Mayo Clinic achieving success and starting to make a difference for patients. Dr. Russell presented the concept of this approach to International Myeloma Working Group (IMWG) members at our annual summit in London in 2011.

New Studies Shed Light on Diet, Obesity in Myeloma and the Anti-Aging Power of Young Blood

As a great fan of Julia Child, I was very pleased to read Mark Bittman's Op-Ed in the New York Times on March 26th: "Butter Is Back." Bittman's piece is based upon a new article in the Annals of Internal Medicine assessing the negative impact of fats in the diet. Researchers from the UK assessed 72 different studies using a methodology called "meta-analysis" whereby many studies can be cross-compared and analyzed together.

China 2014: What's New?

The IMF Asia Pacific team members just returned from China, where we participated in the annual activities of the IMF's Chinese Myeloma Working Group (CMWG).

Black Swan, Salamanca, and the FDA: Debut of a Highly Sensitive New MRD Test

A significant event in the evolution of the IMF's Black Swan Research Initiative occurred this past weekend in Salamanca, Spain.

Measuring Minimal Residual Disease in Myeloma

A recent editorial in Leukemia authored by doctors Shaji Kumar and Vincent Rajkumar of the Mayo Clinic in Rochester, MN, provides a thoughtful overview of the current status of minimal residual disease (MRD) assessment in myeloma.

Pages